The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trialStephen Phillips, G.S. Venables, Anna Członkowska et al.|The Lancet|2012Cited by 1.2k
Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trialLeo H. Bonati, Fiona Kennedy, John Gregson et al.|The Lancet Neurology|2018Cited by 178
Brain iron accumulation in Wilson disease: a <i>post mortem</i> 7 Tesla MRI – histopathological studyPetr Dušek, Jens Wuerfel, Erik Bahn et al.|Neuropathology and Applied Neurobiology|2016Cited by 76
Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)J. Donald Easton, David Paulon, Maria Aunes et al.|Circulation|2017Cited by 33